FDA NDC Directory · JSON-LD · Markdown

Naproxen

NDC 0054-3630 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerHikma Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA074190
Dosage form / routeSUSPENSION · ORAL
Active ingredientsNAPROXEN (125 mg/5mL)
Marketing started20210224
Package count1

External sources

Source: openFDA. Public-domain (CC0).